FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Manufacturer

Country

Certificates

FDA

Document

No Title 0.31 MB
Registration Date 10 Oct 2016
Share

SYLATRON™

Medicine Pharmaceuticals Product Number : 0085-4349-01

Antineoplastic Agent

Drug Information

Generic
Peginterferon alfa-2b
NDC Code
0085-4349-01
Therapeutic Class
Antineoplastic Agent
Dosage form
kit
Route of Administration
SUBCUTANEOUS
Therapeutic Area
1.Antiviral interferons 2.melanoma

Indication

Sylatron™ is an alpha interferon indicated for the adjuvant treatment of melanoma with microscopic or gross nodal involvement within 84 days of definitive surgical resection including complete lymphadenectomy.

Benefit

Sylatron (peginterferon alfa-2b) is made from human proteins that help the body fight viral infections